BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gregório PC, Favretto G, Sassaki GL, Cunha RS, Becker-Finco A, Pecoits-Filho R, Souza WM, Barreto FC, Stinghen AEM. Sevelamer reduces endothelial inflammatory response to advanced glycation end products. Clin Kidney J 2018;11:89-98. [PMID: 29423208 DOI: 10.1093/ckj/sfx074] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Maciel RAP, Cunha RS, Busato V, Franco CRC, Gregório PC, Dolenga CJR, Nakao LS, Massy ZA, Boullier A, Pecoits-Filho R, Stinghen AEM. Uremia Impacts VE-Cadherin and ZO-1 Expression in Human Endothelial Cell-to-Cell Junctions. Toxins (Basel) 2018;10:E404. [PMID: 30301260 DOI: 10.3390/toxins10100404] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
2 Smith C, Swart A. Aspalathus linearis (Rooibos) - a functional food targeting cardiovascular disease. Food Funct 2018;9:5041-58. [PMID: 30183052 DOI: 10.1039/c8fo01010b] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 5.7] [Reference Citation Analysis]
3 Vila Cuenca M, Hordijk PL, Vervloet MG. Most exposed: the endothelium in chronic kidney disease. Nephrol Dial Transplant 2020;35:1478-87. [PMID: 31071222 DOI: 10.1093/ndt/gfz055] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
4 Ortiz A, Vinck C. The new Clinical Kidney Journal, 4 years later. Clin Kidney J 2019;12:1-5. [PMID: 30746126 DOI: 10.1093/ckj/sfy139] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Gregório PC, Bucharles S, Cunha RSD, Braga T, Almeida AC, Henneberg R, Stinghen AEM, Barreto FC. In vitro anti-inflammatory effects of vitamin D supplementation may be blurred in hemodialysis patients. Clinics (Sao Paulo) 2021;76:e1821. [PMID: 33624705 DOI: 10.6061/clinics/2021/e1821] [Reference Citation Analysis]
6 Dong L, Li J, Lian Y, Tang ZX, Zen Z, Yu P, Li Y. Long-Term Intensive Lifestyle Intervention Promotes Improvement of Stage III Diabetic Nephropathy. Med Sci Monit 2019;25:3061-8. [PMID: 31022160 DOI: 10.12659/MSM.913512] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
7 Onal EM, Afsar B, Covic A, Vaziri ND, Kanbay M. Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease. Hypertens Res 2019;42:123-40. [PMID: 30504819 DOI: 10.1038/s41440-018-0144-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
8 Vallée M, Weinstein J, Battistella M, Papineau R, Moseley D, Wong G. Multidisciplinary Perspectives of Current Approaches and Clinical Gaps in the Management of Hyperphosphatemia. Int J Nephrol Renovasc Dis 2021;14:301-11. [PMID: 34393498 DOI: 10.2147/IJNRD.S318593] [Reference Citation Analysis]
9 Huang YC, Tsai TC, Chang CH, Chang KT, Ko PH, Lai LC. Indoxyl Sulfate Elevated Lnc-SLC15A1-1 Upregulating CXCL10/CXCL8 Expression in High-Glucose Endothelial Cells by Sponging MicroRNAs. Toxins (Basel) 2021;13:873. [PMID: 34941711 DOI: 10.3390/toxins13120873] [Reference Citation Analysis]
10 Cunha RSD, Santos AF, Barreto FC, Stinghen AEM. How do Uremic Toxins Affect the Endothelium? Toxins (Basel) 2020;12:E412. [PMID: 32575762 DOI: 10.3390/toxins12060412] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
11 Garay-Sevilla ME, Gomez-Ojeda A, González I, Luévano-Contreras C, Rojas A. Contribution of RAGE axis activation to the association between metabolic syndrome and cancer. Mol Cell Biochem 2021;476:1555-73. [PMID: 33398664 DOI: 10.1007/s11010-020-04022-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
12 Ogata H, Takeshima A, Ito H. An update on phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a review of safety profiles. Expert Opin Drug Saf 2022. [PMID: 35180026 DOI: 10.1080/14740338.2022.2044472] [Reference Citation Analysis]
13 Biruete A, Hill Gallant KM, Lindemann SR, Wiese GN, Chen NX, Moe SM. Phosphate Binders and Nonphosphate Effects in the Gastrointestinal Tract. J Ren Nutr 2020;30:4-10. [PMID: 30846238 DOI: 10.1053/j.jrn.2019.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
14 Barreto FC, Barreto DV, Massy ZA, Drüeke TB. Strategies for Phosphate Control in Patients With CKD. Kidney Int Rep 2019;4:1043-56. [PMID: 31440695 DOI: 10.1016/j.ekir.2019.06.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
15 Wang J, Xiang H, Lu Y, Wu T, Ji G. New progress in drugs treatment of diabetic kidney disease. Biomed Pharmacother 2021;141:111918. [PMID: 34328095 DOI: 10.1016/j.biopha.2021.111918] [Reference Citation Analysis]
16 Falconi CA, Junho CVDC, Fogaça-Ruiz F, Vernier ICS, da Cunha RS, Stinghen AEM, Carneiro-Ramos MS. Uremic Toxins: An Alarming Danger Concerning the Cardiovascular System. Front Physiol 2021;12:686249. [PMID: 34054588 DOI: 10.3389/fphys.2021.686249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wang X, Li R, Zacharek A, Landschoot-Ward J, Chopp M, Chen J, Cui X. ApoA-I Mimetic Peptide Reduces Vascular and White Matter Damage After Stroke in Type-2 Diabetic Mice. Front Neurosci 2019;13:1127. [PMID: 31708728 DOI: 10.3389/fnins.2019.01127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]